Does BEVACIZUMAB-BVZR Cause Red cell distribution width increased? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Red cell distribution width increased have been filed in association with BEVACIZUMAB-BVZR. This represents 1.6% of all adverse event reports for BEVACIZUMAB-BVZR.
9
Reports of Red cell distribution width increased with BEVACIZUMAB-BVZR
1.6%
of all BEVACIZUMAB-BVZR reports
5
Deaths
5
Hospitalizations
How Dangerous Is Red cell distribution width increased From BEVACIZUMAB-BVZR?
Of the 9 reports, 5 (55.6%) resulted in death, 5 (55.6%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-BVZR. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-BVZR Cause?
Off label use (159)
Death (149)
Neoplasm progression (80)
Fatigue (57)
Hypertension (41)
Blood pressure increased (39)
Weight decreased (39)
Weight increased (34)
Inappropriate schedule of product administration (28)
Malaise (28)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which BEVACIZUMAB-BVZR Alternatives Have Lower Red cell distribution width increased Risk?
BEVACIZUMAB-BVZR vs BEVACIZUMAB-MALY
BEVACIZUMAB-BVZR vs BEXAROTENE
BEVACIZUMAB-BVZR vs BEZAFIBRATE
BEVACIZUMAB-BVZR vs BEZLOTOXUMAB
BEVACIZUMAB-BVZR vs BGB-11417